Sign in with Google
|
USD 10.41
Price
0.31
(3.07%)
Day Change
|
|
|---|
YMAB, ファンダメンタルスコアはnot good (ファンダメンタル = 38) そしてテクニカルスコアは ...(Sign In to See)...
Loading chart...
- Signal
- UNDERPERFORM
- Signal Description
- Company financial health is Not Good
- Reason
-
ROEが低い
ROAが低い
平均ROEが低い
ROEが昨年度比で低い
ROAの伸びが低い
NPMが低い
NPMの伸びが低い
NPMの伸びが低い
In details, quality factors are not good , financial health is not good , and ability to make profit is not quite good , ...
| Deepscope 分析 |
|
39% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| Social Score | 4 |
| Magic Formula Rank by ROA |
N/A
|
| Magic Formula Rank by ROE |
N/A
|
| Magic Formula Rank by ROIC |
N/A
|
| Price | 10.41 |
| PBV / Sector |
5.04 / 1.80
|
| Earning Per Share | -0.54 |
| PE / Sector |
N/A / 17.15
|
| PEG or PE/Growth / Sector |
N/A / 5.47
|
| Average 1M Daily Value |
3.69 M
GREAT
|
| Average 1W Daily Value |
2.71 M
GREAT
|
| Timing Factors |
|
42% |
| Financial Health |
|
45% |
| ポイントになる統計 |
|
52% |
| 配当 |
|
4% |
| 登録情報 |
| Analyze Date | 2024-11-23 19:34:20 |
| Symbol | YMAB |
| Name | Y MABS THERAPEUTICS |
| Sector | Healthcare >> Biotechnology |
| Market | NASDAQ |
| Listed Shares | 44.79 M |
| Par Value | N/A |
| Calculated From | Quarter |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 466.25 / 3,546.86 |
| ニュース |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
EXEL 
RPRX 
